Concepedia

Hongxi Wu

HW

14

Publications

451

Citations

12

H-Index

2016

Active since

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

National University of Singapore

National Institute of Environmental Health Sciences

Jiangsu Province Hospital

Hongxi Wu is an author at China Pharmaceutical University specializing in medicine, medicinal chemistry, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2023

14

Publications

14

Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells

Yan Cheng, Xin‐Ying Tang, Yixuan Li et al. · Clinical Cancer Research · 2018 · 88 citations · Full text

Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway

Yan Cheng, Xinghua Gao, Xian-Jing Li et al. · Oncogene · 2018 · 78 citations · Full text

, , +10

Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment

Xu Wang, Jie Mao, Tao Zhou et al. · Theranostics · 2020 · 53 citations · Full text

MiR‐21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway

Fu Gui, Zhengdong Hong, Zhipeng You et al. · Cell Biology International · 2016 · 38 citations

, , +14

Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti–programmed cell death protein‐1 therapy

Hongxi Wu, Li Yan, Guangjiang Shi et al. · Hepatology · 2022 · 33 citations · Full text

Rows per page

1–5 of 14